Solta in Agreement to Acquire Newly Approved LIPOSONIX
Solta Medical has entered into a stock purchase agreement with Medicis Pharmaceutical Corporation to acquire all outstanding shares of Medicis Technologies (formerly LipoSonix, Inc.), a subsidiary of...
View ArticleValeant Pharmaceuticals Completes Acquisition Of Solta Medical
Valeant Pharmaceuticals International has completed its acquisition of aesthetic device manufacturer Solta Medical at a price of $2.92 per share in cash, or approximately $250 million in the aggregate....
View Article
More Pages to Explore .....